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ABSTRACT
Background: Zinc is an essential element required for the cell metabolism, including gene transcription, sig-
nal transduction, immunity, and apoptosis. The pathophysiological role of zinc in asthma, however, is not en-
tirely clear. Mast cells have been implicated in atopic asthma, and zinc deprivation has been reported to reduce
mast cell activation. Here, we investigate the effects of a zinc chelator, N,N,N’,N’-tetrakis (2-pyridyl-methyl) eth-
ylenediamine (TPEN), on asthmatic responses in mouse models of ovalbumin (OVA)-induced airway hyperre-
sponsiveness and allergic airway inflammation.
Methods: Mice were sensitized with OVA with or without the adjuvant aluminum hydroxide (alum) and sub-
jected to OVA exposure with or without treatment of TPEN. Cell profiles and cytokine levels in bronchoalveolar
lavage (BAL) fluids, airway responsiveness to inhaled acetylcholine, and goblet cell hyperplasia after allergen
exposure were assessed.
Results: In mice sensitized to OVA without alum, TPEN significantly suppressed airway hyperresponsiveness
and eosinophilia in BAL fluids. TPEN also attenuated the upregulation of TNFα, IL-13 and IL-4 in BAL fluids
and goblet cell hyperplasia after OVA exposure. By contrast, in mice sensitized to OVA with alum, TPEN sup-
pressed eosinophilia in BAL fluids but not airway hyperresponsiveness and goblet cell hyperplasia.
Conclusions: In pulmonary allergic inflammation induced in mice immunized with antigen without alum, zinc
chelator inhibits airway inflammation and hyperresponsiveness. These findings suggest that zinc may be a
therapeutic target of allergic asthma.
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INTRODUCTION
Bronchial asthma is a chronic inflammatory disease
characterized by eosinophilic inflammation, airway
hyperresponsiveness (AHR) to bronchospastic stim-
uli, and remodeling of the airways.1-3 The airway in-
flammation in asthma is associated with a T helper
(Th) 2-type immune response in which Th2 cell-
derived cytokines, such as interleukin (IL)-4, IL-5, IL-
9, and IL-13, are considered to contribute to eosino-
phil infiltration, AHR, and mucus hypersecretion.4,5
IL-4 and IL-13 also have critical roles in antigen-
specific immunoglobulin (Ig) E production in atopic
asthma, eliciting antigen-dependent and IgE-
dependent mast cell and basophil activation.6
Mast cells are important effector cells in innate or
acquired immunity and contribute to the develop-
ment of allergic diseases, including atopic asthma.
When mast cells are activated, potent inflammatory
mediators are released in an antibody-dependent
manner.7,8 FcεRIα-deficient mice exhibit reduced air-
way inflammation and AHR in a mice allergic asthma
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model.9
Zinc is an essential element required for many cel-
lular functions, especially immunity. Zinc-dependent
biological function includes DNA replication, RNA
transcription, signal transduction, enzymatic cataly-
sis, redox regulation, cell proliferation, cell differen-
tiation, and apoptosis.10-12 Zinc is conventionally
thought to protect airway epithelial cells as an antioxi-
dant, an anti-inflammatory factor, and an inhibitor of
apoptosis.13 However, recent studies indicate that
zinc deprivation inhibits CC chemokine production in
human epithelial cells14 and reduces mast cell activa-
tion15 in bone marrow-derived mast cells. However,
the pathophysiological role of zinc in allergic airway
disease has not been clarified.
Although most mouse models of allergic airway in-
flammation involve sensitizing the mice with antigen
admixed with aluminum hydroxide (alum), alum can
enhance Th2 responses in the absence of IL-4 recep-
tor α, which is essential for IL-4 and IL-13 signals.16 A
recent study demonstrated that mast cells contribute
significantly to the allergic airway inflammation in-
duced by ovalbumin (OVA) challenge in mice sensi-
tized with OVA without alum.17,18 Mast cell granules
are rich in zinc, which is essential for FcεRI-mediated
activation and required for degranulation and cy-
tokine production.15 In the present study, we investi-
gate the effects of a zinc chelator, N,N,N’,N’-tetrakis
(2-pyridyl-methyl) ethylenediamine (TPEN), on asth-
matic responses in vivo.
METHODS
ANIMALS
Male C57BL6J or BALBc mice of 8 to 10 weeks of
age were purchased from Japan SLC, Inc. (Shizuoka,
Japan) and used in this protocol. All procedures and
protocols were approved by the Kyushu University
Animal Care and Use Committee.
ZINC CHELATOR N,N,N’,N’ -TETRAKIS (2-
PYRIDYL-METHYL) ETHYLENEDIAMINE (TPEN)
TPEN was prepared according to the method de-
scribed previously.19 Briefly, TPEN was dissolved in
a vehicle consisting of ethanol: glycerol: H2O in a ra-
tio of 1 : 3 : 6 and injected intraperitoneally 30 min be-
fore allergen exposure or IL-13 instillation.
OVA SENSITIZATION AND CHALLENGE
C57BL6J mice were sensitized with intraperitoneal
injections of 10 μg OVA (Grade V, SIGMA, St. Louis,
MO, USA) without aluminum hydroxide (Thermo
Scientific, Rockford, IL, USA) every other day for 14
days in a mast cell-dependent mice model of allergic
asthma.20 On days 40, 43, and 46, mice received an
aerosol challenge containing either saline or 1% OVA
for 30 min per day. Mice received an intraperitoneal
injection of 10 mgkg TPEN or vehicle solution 30
min before each OVA challenge. On day 47, 24 h after
the last aerosol challenge, measurements of the air-
way responsiveness and bronchoalveolar lavage
(BAL) were performed. In a mast cell-independent
model, mice were sensitized with intraperitoneal in-
jections of 20 μg OVA plus 2.25 mg alum on days 1
and 14 and challenged with 1% OVA solution for 30
min on days 28, 29, and 30. Mice received an intrape-
ritoneal injection of 10 mgkg TPEN or vehicle solu-
tion 30 min before each OVA challenge. On day 32,
24 h after the last aerosol challenge, measurements
of the airway responsiveness and BAL were per-
formed.
INTRATRACHEAL INSTILLATION OF IL-13
BALBc mice were injected with 2 μg IL-13 intratra-
cheally on days 1, 3, and 5 as described previously.21
Mice received an intraperitoneal injection of TPEN or
vehicle solution 30 min before each instillation. On
day 6, measurements of the airway responsiveness
and BAL were performed.
MEASUREMENT OF AIRWAY RESPONSIVE-
NESS
Mice were anesthetized, and their tracheas were can-
nulated via tracheostomy. The animals were venti-
lated to measure AHR to acetylcholine aerosol as de-
scribed previously.21 The airway opening pressure
was measured with a differential pressure transducer
and continuously recorded. Stepwise increases in the
acetylcholine dose were given with an ultrasonic
nebulizer. The data are expressed as the provocative
concentration 200 (PC200), the concentration at which
airway pressure was 200% of its baseline value, and
PC200 was calculated by log-linear interpolation for in-
dividual mice. Lower log PC200 values represent
greater AHR.
BAL AND CELL COUNTING
Mice were given a lethal dose of pentobarbital, and
lungs were gently lavaged one time with 1.0 ml saline
via the tracheal cannula. Total cell counts and differ-
ential counts were performed.21
HISTOLOGICAL ASSESSMENT
Lungs were fixed with 10% formalin, and tissue sec-
tions were stained with Periodic acid-SchiffAlcian
blue (PASAB) to assess goblet cell hyperplasia in
the airways after antigen exposure.
MEASUREMENT OF CYTOKINE LEVEL AND
OVA-SPECIFIC IgE
Mouse IL-4 (Biosource, Camarillo, CA, USA), IL-13
(R&D Systems, Inc., Minneapolis, MN, USA), and
TNF-α (Biosource) levels in the supernatant of BAL
fluids were measured using ELISA kits. The concen-
tration of serum OVA-specific IgE was measured us-
ing ELISA kits (Shibayagi Co., Ltd., Gunma, Japan).
TPEN and Airway Hyperresponsiveness
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Fig.　1　Effect of TPEN on airway responsiveness to inhaled acetylcholine 
(ACh) after OVA challenges. A. TPEN attenuates AHR to inhaled ACh in 
OVA sensitization without alum model. Airway responsiveness was deter-
mined by the ACh-dependent change in airway pressure. B. TPEN treat-
ment before OVA challenges suppressed AHR after antigen challenges in 
sensitization without alum model. The provocative concentration 200 
(PC200-ACh), at which airway pressure was 200% of its baseline value, is 
expressed as log (PC200-ACh × 100). Lower log PC200 values represent 
greater AHR. C. Effect of TPEN on AHR to inhaled ACh in OVA sensitiza-
tion with alum model. TPEN did not affect AHR after OVA exposure in this 
model. The values are the means ± SEM. n = 6 to 7. *p < 0.05. NS, not sig-
nifi cant.
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EFFECT OF TPEN ON EOTAXIN-1 LEVELS AF-
TER IL-13 STIMULATION IN VITRO
BEAS-2B cells, a human airway epithelial cell line,
were cultured in DMEMF-12 medium, with 10%
FBS, penicillin, and streptomycin. The cells were
treated with TPEN at indicated concentrations for 2
hours and were stimulated with human recombinant
IL-13 (30 ngml). Twenty-four hours later, superna-
tant of cell culture was collected and eotaxin-1 levels
were measured using ELISA kit (Biosource).
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Fig.　2　Effect of TPEN on eosinophil counts in BAL fl uid after antigen challenges. A. Eo-
sinophil counts in OVA sensitization without alum model. B. Eosinophil counts in OVA sen-
sitization with alum model. TPEN treatment before antigen challenges suppressed eosino-
philic infl ammation in both model. Vehicle or TPEN solution was administered to OVA-
sensitized mice 30 minutes before OVA challenges. BAL fl uids were collected from vehicle 
alone, TPEN alone, vehicle-OVA, or TPEN-OVA mice. TPEN attenuates eosinophilia in 
BAL fl uid. n = 5 to 7. *p < 0.05.
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DATA ANALYSIS
Values are expressed as the means ± SEM. Differ-
ences between groups were analyzed by analysis of
variance, and the significance of differences between
values was assessed by Bonferroni correction. Values
of p < 0.05 were considered significant.
RESULTS
EFFECT OF TPEN ON ALLERGEN-INDUCED
AIRWAY RESPONSES
In a mast cell-dependent model, OVA sensitization
without alum and challenges resulted in AHR to in-
haled acetylcholine. Treatment with TPEN during the
effector phase of allergic responses attenuated AHR
after OVA challenges (Fig. 1A, 1B). When alum was
used for an adjuvant, AHR after OVA challenges was
not affected by TPEN (Fig. 1C). These results sug-
gest that TPEN affects AHR, at least in part, via a
mast cell-dependent pathway. There were no signifi-
cant differences in the baseline values of airway pres-
sure among the control, TPEN alone, OVA challenge
alone, and OVA plus TPEN.
EFFECT OF TPEN ON EOSINOPHILIC INFLAM-
MATION
OVA sensitization and challenges resulted in an in-
creased number of eosinophil in BAL fluids. TPEN
treatment decreased eosinophil counts in BAL fluid
after OVA challenges in allergic asthma models both
with and without alum (Fig. 2A, 2B). TPEN did not
change the number of macrophages, neutrophils, or
lymphocytes in BAL fluid after antigen challenges.
EFFECT OF TPEN ON GOBLET CELL HYPER-
PLASIA
Histologically, eosinophil infiltration around the air-
way after allergen exposure was suppressed by
TPEN treatment in both models sensitized with or
without alum (data not shown). TPEN inhibited gob-
let cell hyperplasia after OVA challenges without
alum model. On the other hand, TPEN treatment had
no effect on goblet cell hyperplasia in sensitization
with alum model (Fig. 3).
EFFECT OF TPEN ON OVA-SPECIFIC IgE
The OVA-specific IgE concentration measured in
sera after OVA challenges was significantly in-
creased. Treatment with TPEN did not affect the se-
rum OVA-specific IgE levels (Fig. 4). Thus, a zinc
chelator administered only in the effector phase of al-
lergic responses did not appear to influence the pro-
duction of OVA-specific IgE.
EFFECT OF TPEN ON CYTOKINE LEVELS IN
BAL FLUID
We next measured the levels of Th2 cytokines, IL-4
and IL-13, and TNFα, because TNFα has been re-
ported to contribute to an allergic airway inflamma-
tion in IgE-dependent and mast cell-dependent
mouse models.18 OVA challenge resulted in in-
creases in these cytokines in BAL fluids. The levels of
TNFα, IL-13 and IL-4 in BAL fluids were more re-
TPEN and Airway Hyperresponsiveness
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Fig.　3　Effect of TPEN on goblet cell hyperplasia. Representative light photomicrographs of mouse lung 
tissue stained with Periodic acid-Schiff - Alcian blue (PAS/AB) to identify goblet cells (original magnifi ca-
tion: ×200). There are marked increases in goblet cells in the epithelium of the intrapulmonary bronchus 
24 h after OVA exposures. Treatment with TPEN caused marked decreases in the levels of PAS/AB 
staining cells after antigen challenges in mice sensitization without alum (Left panels). TPEN had no ef-
fect on the levels of PAS/AB staining cells after OVA challenges in mice sensitization with alum (Right 
panels).
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Fig.　4　Effect of TPEN on serum OVA-specifi c IgE level af-
ter allergen exposure. TPEN did not affect OVA-specifi c IgE
level after OVA challenges. Serum OVA-specifi c IgE was an-
alyzed by ELISA. n = 5 to 7. NS, not signifi cant.
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duced in TPEN-treated mice than in vehicle-treated
mice in allergic asthma model without alum
(Fig. 5A). TPEN treatment reduced the upregulation
of IL-13 levels in BAL fluids in asthma model sensi-
tized with alum. On the other hand, TNFα levels
were not affected by TPEN treatment in this model
(Fig. 5B).
EFFECT OF TPEN ON EOSINOPHILIC INFLAM-
MATION AFTER IL-13 TREATMENT
The increase in eosinophils in BAL fluids after IL-13
instillation was suppressed by TPEN treatment (Fig.
6A). Furthermore, TPEN suppressed eotaxin-1 pro-
duction from airway epithelial cells after IL-13 treat-
ment in vitro dose-dependently (Fig. 6B). These re-
sults suggest that TPEN modulates chemokine and
cytokine production from airway epithelial cells.
DISCUSSION
Although zinc is thought to protect airway cells, re-
cent studies indicate that zinc contributes to mast cell
activation15 and chemokine production from epithe-
lial cells.14 The pathophysiological role of zinc in al-
lergic airway responses has not been clarified. In the
present study, we demonstrated that a zinc chelator,
TPEN, attenuates AHR and eosinophilic inflammation
in mast cell-dependent mice model of allergic asthma.
These findings suggest that zinc is involved in aller-
gic airway inflammation and hyperresponsiveness in
vivo.
TPEN suppressed the upregulation of TNFα, IL-13
and IL-4 in the airways. Th2-type cytokines, such as
Fukuyama S et al.
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Fig.　5　Effect of TPEN on cytokine levels in BAL fl uids after antigen exposure. BAL fl uids 
were obtained from vehicle alone, TPEN alone, or vehicle-OVA, TPEN-OVA mice. The cy-
tokine profi les in BAL supernatants were analyzed by ELISA. A. Cytokine profi les in OVA 
sensitization without alum model. Elevated TNF-α, IL-13 and IL-4 levels in BAL fl uids after 
allergen exposures were reduced in TPEN-treated mice. n = 7 to 9. *p < 0.05. B. Cytokine 
profi les in OVA sensitization with alum model. Elevated IL-13 but not TNF-α levels in BAL 
fl uids after allergen exposures were reduced in TPEN-treated mice. n = 5 to 7. *p < 0.05. 
NS, not signifi cant.
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IL-4 and IL-13, have been implicated in the induction
of AHR and allergic airway inflammation.4 The impor-
tance of TNFα, especially from mast cells, in the
manifestation of various phenotypes in mouse models
of allergic asthma has been reported.17 In addition to
Th2 cells, mast cells can also produce IL-4. Because
TPEN did not affect serum IgE concentration, TPEN
might suppress the activation of mast cells during al-
lergic airway responses.
Epithelial cells and fibroblasts are the main source
of cytokines and chemokines in the airways of bron-
chial asthma. The zinc chelator inhibits the produc-
tion of CC chemokine, such as eotaxin-1, eotaxin-2,
RANTES, MCP-1, after TNFα treatment in lung epi-
thelial cell and fibroblast in vitro.14 After IL-13 treat-
ment, the increase in eosinophils in BAL fluid was
suppressed by TPEN treatment. Moreover, eotaxin-1
production from airway epithelial cells after IL-13
stimulation was attenuated by TPEN treatment in vi-
tro. These results suggest that TPEN inhibits
chemokine production after IL-13 instillation from air-
way epithelial cells.
Zinc signals are very important in many cell types
of immune system, including dendritic cells, mono-
cytes, mast cells, and T cells.22 T cell function is sus-
ceptible to zinc deprivation and zinc signals activate
protein kinase C in T cells23 and promote IL-2-
dependent T cell proliferation.24 In allergic airway in-
flammation models, T cells have critical role in the
development of AHR. In OVA sensitization with alum
protocol, TPEN did not affect AHR, TNFα levels in
BAL fluids and goblet cell hyperplasia after antigen
challenges. On the other hand, TPEN attenuated
AHR, TNFα levels and goblet cell hyperplasia after
TPEN and Airway Hyperresponsiveness
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Fig.　6　A. Effect of TPEN on eosinophil counts in BAL fl uid after IL-13 instillation. Eosino-
phil counts were attenuated by TPEN treatment after IL-13 instillation in vivo. n = 5 to 7. *p < 
0.05. B. Effect of TPEN on eotaxin-1 levels in the supernatant of airway epithelial cells af-
ter IL-13 treatment. TPEN dose-dependently suppressed eotaxin-1 production from BEAS-
2B cells after IL-13 stimulation in vitro. n = 6. *p < 0.05.
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OVA challenge in sensitization without alum protocol.
The previous study demonstrated that mast cell and
mast cell-derived TNFα is essential for both AHR and
eosinophilic airway inflammation in the model sensi-
tized without alum, and not in the mice sensitized
with alum.17 The exact mechanism of the discrepancy
between the inhibitory effects of TPEN on AHR and
airway eosinophilia in mast cell-independent model is
uncertain. Airway mucus hypersecretion contributes
AHR.25 Administration of TNFα into the lungs of
mice increases airway mucus gene expression,26 and
TNFα induces the late-phase AHR.27 The failure of
TPEN to inhibit TNFα might affect goblet cell hyper-
plasia and AHR under the condition of IL-13 suppres-
sion by TPEN.
A known adverse effect of TPEN is convulsions.28
In general, the heavy metal chelator has neuronal cy-
totoxicity in the hippocampus.29 Thus, a safer chela-
tor or inhaled agent may be needed for clinical appli-
cations.
In conclusion, we provide evidence that TPEN at-
tenuates AHR and airway inflammation induced by al-
lergens in a mast cell-dependent mouse model. The
extent to which our observations can be extended to
human asthma remains to be determined. However,
the present findings raise the possibility that a zinc
chelator has potential therapeutic implications for
bronchial asthma.
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